Faropenem Sodium Extended Release 300 mg Tablets – FAROCYL 300 ER

Faropenem Sodium Extended Release 300 mg Tablets  – A dual-core inhibitor to fix complicated infections.
FAROCYL 300 ER – Faropenem sodium Extended Release Tablets 300 mg is a next-generation oral beta-lactam antibiotic with established efficacy and safety in managing a wide range of community-acquired infections.
Enhanced chemical stability and minimized CNS side effects compared to imipenem.
Proven effectiveness —A 7-day course of Faropenem in treating acute bacterial rhinosinusitis is as effective clinically and bacteriologically as a 10-day course of Cefuroxime Axetil.

Recommended by specialists:
✅Pulmonologists – Used in treating community-acquired pneumonia, acute exacerbations of chronic bronchitis, and upper respiratory tract infections.
✅General Physicians – For various bacterial infections, including complicated UTIs, intra-abdominal infections, and skin infections.

Key Benefits:
✅Broad-Spectrum Antimicrobial Action – Effective against both gram-positive and gram-negative bacteria.
✅Ideal for Step-Down Therapy – A convenient oral option for continued treatment post-hospital discharge.
✅High Efficacy with a Favorable Safety Profile – Well-tolerated and effective in managing complex infections.

Indications:
✅Faropenem is a reliable treatment option for various complicated infections, including:
✅Complicated intra-abdominal infections
✅Complicated urinary tract infections
✅Community-acquired pneumonia
✅Skin and soft tissue infections
✅Upper respiratory tract infections
✅Acute exacerbation of chronic bronchitis
✅Acute bacterial sinusitis